HIV Roundtable : Episode 1

HIV Roundtable: Managing medications after diagnosis

News
Video

Expert discussion of several topics including diagnosis, clinical management in older adults, multidrug resistance, and long-acting injectables and PrEP.

HIV Roundtable:

Welcome to the first episode of our 3-episode series; HIV Roundtable, a collaborative project from Contemporary Pediatrics, Contagion, and Contemporary OB/GYN.

This series discusses several aspects of HIV including clinical management, therapies, vaccines, and multidrug resistance.

In this episode, our panel offers their approaches to care in terms of medications and management when patients are first diagnosed and a discussion around long-acting injectables for HIV management.

Panel:

  • MJ Kasten, MD,associate professor of Medicine, consultant, Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Internal Medicine, Mayo Clinic
  • Natasha Hoyte, MPH, CPNP-PC, New York-Presbyterian School Based Health Centers
  • Aimalohi Ahonkhai, MD, MPH, associate physician, medicine at the Massachusetts General Hospital, associate director of the Bio-behavioral and Community Science Core and director of the Community Engaged Research Program for the Harvard University Center for AIDS Research
  • Jessica Castilho, MD, associate professor of Medicine, Division of Infectious Diseases, associate professor, Dept. of Health Policy, Vanderbilt University Medical Center
Recent Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Natasha Hoyte, MPH, CPNP-PC
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Deborah Persaud, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.